Medtronic (MDT) Gains from Investment Securities (2014 - 2026)

Medtronic's Gains from Investment Securities history runs 13 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 230.84% year-over-year to $1.8 billion; the TTM figure through Jan 2026 stood at $1.9 billion (up 263.48% YoY), while the FY2025 annual figure was $249.0 million, down 4.6% from the prior year.
• Gains from Investment Securities came in at $1.8 billion for Q1 2026 at Medtronic, up from -$292.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.8 billion in Q1 2026 to a low of -$1.4 billion in Q1 2024.
• A 5-year average of $269.0 million and a median of $154.0 million in 2022 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities slumped 3944.12% in 2024 and jumped 1288.89% in 2025, its largest moves.
• Medtronic's Gains from Investment Securities stood at -$408.0 million in 2022, then jumped by 343.38% to $993.0 million in 2023, then surged by 33.53% to $1.3 billion in 2024, then sank by 122.02% to -$292.0 million in 2025, then jumped by 704.45% to $1.8 billion in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.8 billion, -$292.0 million, and $125.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison